Protective Efficacy of Pneumococcal Polysaccharide Vaccines

JAMA: The Journal of the American Medical Association

Volumn 238, Issue 24, 1977, Pages 2613-2616

  Smit, Pieter ^a   Oberholzer, Dennis ^a   Hayden Smith, Stanley ^b   Koornhof, Hendrik J ^b   Hilleman, Maurice R ^c  

^a GOLD FIELDS LIMITED   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; PROTECTIVE AGENT;

DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; PNEUMONIA; PREVENTION; SOUTH AFRICA;

ADULT; ANTIBODY FORMATION; BACTERIAL VACCINES; CLINICAL TRIALS; GOLD; HUMANS; MALE; MINING; NEISSERIA MENINGITIDIS; OCCUPATIONAL DISEASES; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES, BACTERIAL; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE;

EID: 84943723768     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1977.03280250039019     Document Type: Article

References (16)

1. Statistical Abstract of the United States, ed 94. US Dept of Commerce, Bureau of Census, 1973, p 61.
2. World Health Statistics Annual: Vital Statistics and Causes of Death, Geneva, World Health Organization, 1976, vol 1.
3. Austrian R: Vaccines of pneumococcal capsular polysaccharides and the prevention of pneumococcal pneumonia, in Beers RF Jr, Bassett EG (eds): The Role of Immunological Factors in Infectious, Allergic, and Autoimmune Processes. New York, Raven Press, 1976, p 79.
4. Austrian R: Random gleanings from a life with the pneumococcus. J Infect Dis 131:474-484, 1975.
5. Felton LD: Studies on immunizing substances in pneumococci: VII. Response in human beings to antigenic pneumococcus polysaccharides, types I and II. Public Health Rep 53:1855-1877, 1938.
6. MacLeod CM, Hodges RG, Heidelberger M, et al: Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 82:445-465, 1945.
7. Austrian R, Douglas RM, Schiffman G, et al: Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 89:184-194, 1976.
8. Mufson MA, Kruss DM, Wasil RE, et al: Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 134:505-510, 1974.
9. Lund E: Distribution of pneumococcus types at different times in different areas, in Finland M, Marget W, Bartram K (eds): Bacterial Infections: Changes in Their Causative Agents— Trends and Possible Basis. New York, Springer-Verlag, 1971, p 49.
10. Schiffman G, Austrian R: A radioimmunoassay for the measurement of pneumococcal capsular antigens and of antibodies thereto. Fed Proc 30:658, 1971.
11. Weibel RE, Vella PP, McLean AA, et al: Studies in human subjects of polyvalent pneumococcal vaccines. Proc Soc Exp Biol Med, to be published.
12. Ammann AJ, Addiego J, Wara DW, et al: Polyvalent pneumococcal polysaccharide immunization of patients with sickle cell anemia and patients with splenectomy. N Engl J Med, to be published.
13. Austrian R, Gold J: Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60:759-776, 1964.
14. Fraser DW, Geil CC, Feldman RA: Bacterial meningitis in Bernalillo County, New Mexico: A comparison with three other American populations. Am J Epidemiol 100:29-34, 1974.
15. Kaiser AB, Schaffner W: Prospectus: The prevention of bacteremic pneumococcal pneumonia: A conservative appraisal of vaccine intervention. JAMA 230:404-408, 1974.
16. Bentley DW, Simon SE, Douglas RG, et al: Response to pneumococcal vaccines in healthy elderly volunteers. Read before the Fourteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Sept 11-13, 1974.